The effect of bright light therapy on sleep and circadian rhythms in renal transplant recipients: A pilot randomized, multicentre wait-list controlled trial

Transplant International

Volumn 28, Issue 1, 2015, Pages 59-70

  Burkhalter, Hanna ^a,b   Wirz Justice, Anna ^c   Denhaerynck, Kris ^a   Fehr, Thomas ^d   Steiger, Jürg ^b   Venzin, Reto Martin ^e   Cajochen, Christian ^c   Weaver, Terri Elisabeth ^f   De Geest, Sabina ^a,g  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^g UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

bright light therapy; randomized controlled trial; renal transplantation

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; AZATHIOPRINE; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EVEROLIMUS; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MELATONIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ORAL ANTIDIABETIC AGENT; RAPAMYCIN; TACROLIMUS;

ACTIMETRY; ADULT; ARTICLE; CARDIAC GRAFT REJECTION; CIRCADIAN RHYTHM; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DEPRESSION; DEPRESSION ANXIETY STRESS SCALE; EMOTION; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MULTICENTER STUDY; PATIENT SATISFACTION; PHOTOTHERAPY; PILOT STUDY; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SLEEP; SLEEP DISORDER; SLEEP QUALITY; SLEEP WAKE DISTURBANCE; SYMPTOMATOLOGY; BLOOD; BODY MASS; CLINICAL TRIAL; COGNITIVE DEFECT; HOSPITAL ADMISSION; KIDNEY FAILURE, CHRONIC; LIGHT; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PINEAL BODY; PROCEDURES; REGRESSION ANALYSIS; TIME; WRIST;

ADULT; BODY MASS INDEX; CIRCADIAN RHYTHM; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIGHT; MALE; MELATONIN; MIDDLE AGED; PHOTOTHERAPY; PILOT PROJECTS; PINEAL GLAND; REGRESSION ANALYSIS; SLEEP; TIME FACTORS; WAITING LISTS; WRIST;

EID: 84916232349     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12443     Document Type: Article

References (72)

1. Burkhalter H, Brunner DP, Wirz-Justice A, et al,. Self-reported sleep disturbances in renal transplant recipients. BMC Nephrol 2013; 14: 1.
2. Burkhalter H, Sereika SM, Engberg S, Wirz-Justice A, Steiger J, De Geest S,. Validity of 2 sleep quality items to be used in a large cohort study of kidney transplant recipients. Prog Transplant 2011; 21: 27.
3. Burkhalter H, Wirz-Justice A, Cajochen C, et al,. Validation of a single item to assess daytime sleepiness for the Swiss Transplant Cohort Study. Prog Transplant 2013; 23: 220.
4. Novak M, Molnar MZ, Ambrus C, et al,. Chronic insomnia in kidney transplant recipients. Am J Kidney Dis 2006; 47: 655.
5. Molnar MZ, Novak M, Szeifert L, et al,. Restless legs syndrome, insomnia, and quality of life after renal transplantation. J Psychosom Res 2007; 63: 591.
6. Molnar MZ, Novak M, Mucsi I,. Sleep disorders and quality of life in renal transplant recipients. Int Urol Nephrol 2009; 41: 373.
7. Stoschitzky K, Sakotnik A, Lercher P, et al,. Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol 1999; 55: 111.
8. Murphy PJ, Myers BL, Badia P,. Nonsteroidal anti-inflammatory drugs alter body temperature and suppress melatonin in humans. Physiol Behav 1996; 59: 133.
9. Roux FJ, Kryger MH,. Medication effects on sleep. Clin Chest Med 2010; 31: 397.
10. Molnar-Varga M, Molnar MZ, Szeifert L, et al,. Health-related quality of life and clinical outcomes in kidney transplant recipients. Am J Kidney Dis 2011; 58: 444.
11. Molnar MZ, Mucsi I, Novak M,. Sleep Disorders and Qualiy of Life in Patients After Kidney Transplantation. In:, Vester JC, ed. Sleep and Quality of Life in Clinical Medicine. Totowa, NJ: Humana Press, 2008: 401.
12. Gallicchio L, Kalesan B,. Sleep duration and mortality: a systematic review and meta-analysis. J Sleep Res 2009; 18: 148.
13. Elder SJ, Pisoni RL, Akizawa T, et al,. Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2008; 23: 998.
14. Besedovsky L, Lange T, Born J,. Sleep and immune function. Pflugers Arch 2012; 463: 121.
15. Kapsimalis F, Basta M, Varouchakis G, Gourgoulianis K, Vgontzas A, Kryger M,. Cytokines and pathological sleep. Sleep Med 2008; 9: 603.
16. Castanon-Cervantes O, Wu M, Ehlen JC, et al,. Dysregulation of inflammatory responses by chronic circadian disruption. J Immunol 2010; 185: 5796.
17. American Academy of Sleep Medicine. The International Classification of Sleep Disorders, Diagnostic and Coding Manual, 2nd edn. Weschester, IL: American Academy of Sleep Medicine, in association with the European Sleep Research Society, Japanese Society of Sleep Research, Latin American Sleep Society, 2005: 24 pp.
18. Morin CM, Hauri PJ, Espie CA, Spielman AJ, Buysse DJ, Bootzin RR,. Nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review. Sleep 1999; 22: 1134.
19. Hanford N, Figueiro M,. Light therapy and Alzheimer's disease and related dementia: past, present, and future. J Alzheimers Dis 2013; 33: 913.
20. Saper CB, Lu J, Chou TC, Gooley J,. The hypothalamic integrator for circadian rhythms. Trends Neurosci 2005; 28: 152.
21. Minors DS, Waterhouse JM, Wirz-Justice A,. A human phase-response curve to light. Neurosci Lett 1991; 133: 36.
22. Khalsa SB, Jewett ME, Cajochen C, Czeisler CA,. A phase response curve to single bright light pulses in human subjects. J Physiol 2003; 549 (Pt 3): 945.
23. Kirisoglu C, Guilleminault C,. Twenty minutes versus forty-five minutes morning bright light treatment on sleep onset insomnia in elderly subjects. J Psychosom Res 2004; 56: 537.
24. Czeisler CA, Duffy JF, Shanahan TL, et al,. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 1999; 284: 2177.
25. Burke TM, Markwald RR, Chinoy ED, et al,. Combination of light and melatonin time cues for phase advancing the human circadian clock. Sleep 2013; 36: 1617.
26. Wirz-Justice A, Benedetti F, Terman M,. Chronotherapeutics for Affective Disorders: A Clinician's Manual for Light And Wake Therapy. Basel: Karger, 2009: 9 pp.
27. Terman M, Terman JS,. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectr 2005; 10: 647.
28. Golden RN, Gaynes BN, Ekstrom RD, et al,. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry 2005; 162: 656.
29. Tuunainen A, Kripke DF, Endo T,. Light therapy for non-seasonal depression. Cochrane Database Syst Rev 2004: CD004050.
30. Shirani A, St Louis EK,. Illuminating rationale and uses for light therapy. J Clin Sleep Med 2009; 5: 155.
31. Gooley JJ,. Treatment of circadian rhythm sleep disorders with light. Ann Acad Med Singapore 2008; 37: 669.
32. Schroeder AM, Colwell CS,. How to fix a broken clock. Trends Pharmacol Sci 2013; 34: 605.
33. Montgomery P, Dennis J,. Bright light therapy for sleep problems in adults aged 60 +. Cochrane Database Syst Rev 2002; CD003403.
34. Wirz-Justice A, Krauchi K, Cajochen C, Danilenko KV, Renz C, Weber JM,. Evening melatonin and bright light administration induce additive phase shifts in dim light melatonin onset. J Pineal Res 2004; 36: 192.
35. Terman M, Terman JS,. Bright light therapy: side effects and benefits across the symptom spectrum. J Clin Psychiatry 1999; 60: 799; quiz 9.
36. Lodhi SA, Lamb KE, Meier-Kriesche HU,. Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. Am J Transplant 2011; 11: 1226.
37. Peddi VR, Whiting J, Weiskittel PD, Alexander JW, First MR,. Characteristics of long-term renal transplant survivors. Am J Kidney Dis 1998; 32: 101.
38. Reme CE, Rol P, Grothmann K, Kaase H, Terman M,. Bright light therapy in focus: lamp emission spectra and ocular safety. Technol Health Care 1996; 4: 403.
39. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373.
40. Michalak EE, Murray G, Wilkinson C, Dowrick C, Lam RW,. A pilot study of adherence with light treatment for seasonal affective disorder. Psychiatry Res 2007; 149: 315.
41. Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP,. The role of actigraphy in the study of sleep and circadian rhythms. Sleep 2003; 26: 342.
42. Dallmann R, Lemm G, Niekrenz O,. DaQtix Oetzen, Germany, 2013 [cited 2013 24th March]. Available from: http://daqtix.com/.
43. Kantermann T, Juda M, Merrow M, Roenneberg T,. The human circadian clock's seasonal adjustment is disrupted by daylight saving time. Curr Biol 2007; 17: 1996.
44. Weber J, Schwander J, Unger I, Meier D,. A direct ultrasensitive RIA for the determination of melatonin in human saliva: comparison with serum levels. Sleep Res 1997; 26: 757.
45. Altpeter ES, Roosli M, Battaglia M, Pfluger D, Minder CE, Abelin T,. Effect of short-wave (6-22 MHz) magnetic fields on sleep quality and melatonin cycle in humans: the Schwarzenburg shut-down study. Bioelectromagnetics 2006; 27: 142.
46. Burgess HJ, Fogg LF,. Individual differences in the amount and timing of salivary melatonin secretion. PLoS ONE 2008; 3: e3055.
47. Danilenko KV, Verevkin EG, Antyufeev VS, Wirz-Justice A, Cajochen C,. Hockey-stick method to estimate evening dim light melatonin onset (DLMO). Chronobiol Int 2013; 2014; 31: 349, in press.
48. Lewy AJ,. The dim light melatonin onset, melatonin assays and biological rhythm research in humans. Biol Signals Recept 1999; 8: 79.
49. Lovibond SH, Lovibond PF,. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995; 33: 335.
50. Gloster AT, Rhoades HM, Novy D, et al,. Psychometric properties of the Depression Anxiety and Stress Scale-21 in older primary care patients. J Affect Disord 2008; 110: 248.
51. Crawford JR, Henry JD,. The Depression Anxiety Stress Scales (DASS): normative data and latent structure in a large non-clinical sample. Br J Clin Psychol 2003; 42 (Pt 2): 111.
52. Herbert M, Johns MW, Dore C,. Factor analysis of analogue scales measuring subjective feelings before and after sleep. Br J Med Psychol 1976; 49: 373.
53. Bäumler G,. Farbe-Wort-Interferenztest (FWIT) nach J.R. Stroop [in German]. Göttingen: Hogrefe, 1985: 21 pp.
54. Golden CJ, Freshwater SM,. The Stroop Color and Word Test. Wood Dale, IL: Stoeling Co., 2002: 10 pp.
55. Brismar K, Hylander B, Eliasson K, Rossner S, Wetterberg L,. Melatonin secretion related to side-effects of beta-blockers from the central nervous system. Acta Med Scand 1988; 223: 525.
56. Gradisar M, Dohnt H, Gardner G, et al,. A randomized controlled trial of cognitive-behavior therapy plus bright light therapy for adolescent delayed sleep phase disorder. Sleep 2011; 34: 1671.
57. Chesson AL Jr, Littner M, Davila D, et al,. Practice parameters for the use of light therapy in the treatment of sleep disorders. Standards of Practice Committee, American Academy of Sleep Medicine. Sleep 1999; 22: 641.
58. Gammack JK,. Light therapy for insomnia in older adults. Clin Geriatr Med 2008; 24: 139, viii.
59. Lack LC, Wright HR,. Treating chronobiological components of chronic insomnia. Sleep Med 2007; 8: 637.
60. Chang AM, Santhi N, St Hilaire M, et al,. Human responses to bright light of different durations. J Physiol 2012; 590 (Pt 13): 3103.
61. Ruger M, StHilaire MA, Brainard GC, et al,. Human phase response curve to a single 6.5 h pulse of short-wavelength light. J Physiol 2013; 591 (Pt 1): 353.
62. Even C, Schroder CM, Friedman S, Rouillon F,. Efficacy of light therapy in nonseasonal depression: a systematic review. J Affect Disord 2008; 108: 11.
63. Van der Elst W, Van Boxtel MP, Van Breukelen GJ, Jolles J,. The Stroop color-word test: influence of age, sex, and education; and normative data for a large sample across the adult age range. Assessment 2006; 13: 62.
64. Stoschitzky K, Stoschitzky G, Brussee H, Bonelli C, Dobnig H,. Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol. Cardiology 2006; 106: 199.
65. Dubocovich ML, Markowska M,. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005; 27: 101.
66. Carman JS, Post RM, Buswell R, Goodwin FK,. Negative effects of melatonin on depression. Am J Psychiatry 1976; 133: 1181.
67. Kunz D, Schmitz S, Mahlberg R, et al,. A new concept for melatonin deficit: on pineal calcification and melatonin excretion. Neuropsychopharmacology 1999; 21: 765.
68. Mahlberg R, Kienast T, Hadel S, Heidenreich JO, Schmitz S, Kunz D,. Degree of pineal calcification (DOC) is associated with polysomnographic sleep measures in primary insomnia patients. Sleep Med 2009; 10: 439.
69. Bromundt V, Wirz-Justice A, Kyburz S, Opwis K, Dammann G, Cajochen C,. Circadian sleep-wake cycles, well-being, and light therapy in borderline personality disorder. J Pers Disord 2013; 27: 680.
70. Bromundt V, Koster M, Georgiev-Kill A, et al,. Sleep-wake cycles and cognitive functioning in schizophrenia. Br J Psychiatry 2011; 198: 269.
71. Terman M,. Evolving applications of light therapy. Sleep Med Rev 2007; 11: 497.
72. Burkhalter H, Wirz-Justice A, Cajochen C, et al,. Daytime sleepiness in renal transplant recipients is associated with immunosuppressive non-adherence: a cross-sectional, multi-center study. Clin Transplant 2014; 28: 58.